Abeona therapeutics announces update on aav ophthalmology program

Advancing aav-based gene therapy candidates toward ind studies on encouraging animal proof of concept data in stargardt disease, x-linked retinoschisis (xlrs), and autosomal dominant optic atrophy (adoa)

ABEO Ratings Summary

ABEO Quant Ranking